Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Use of clozapine for the treatment of schizophrenia: findings of the 2006 research on the china psychotropic prescription studies.

Si TM, Zhang YS, Shu L, Li KQ, Liu XH, Mei QY, Wang GH, Bai PS, Ji LP, Cheng XS, Ma C, Shi JG, Zhang HY, Ma H, Yu X.

Clin Psychopharmacol Neurosci. 2012 Aug;10(2):99-104. doi: 10.9758/cpn.2012.10.2.99. Epub 2012 Aug 31.

2.

Clinical correlates of clozapine prescription for schizophrenia in China.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Hum Psychopharmacol. 2007 Jan;22(1):17-25.

PMID:
17191268
3.

Factors that influence the prescription of antipsychotics for patients with schizophrenia in china.

Si TM, Shu L, Li KQ, Liu XH, Mei QY, Wang GH, Bai PS, Ji LP, Chen XS, Ma C, Shi JG, Zhang HY, Ma H, Yu X.

Clin Psychopharmacol Neurosci. 2011 Dec;9(3):122-8. doi: 10.9758/cpn.2011.9.3.122. Epub 2011 Dec 31.

4.

Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009.

Xiang YT, Wang CY, Si TM, Lee EH, He YL, Ungvari GS, Chiu HF, Shinfuku N, Yang SY, Chong MY, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Dixon LB, Kreyenbuhl JA, Tan CH.

Aust N Z J Psychiatry. 2011 Nov;45(11):968-75. doi: 10.3109/00048674.2011.607426. Epub 2011 Sep 3.

PMID:
21888603
5.

Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.

Wheeler AJ.

Ann Pharmacother. 2008 Jun;42(6):852-60. doi: 10.1345/aph.1K662. Epub 2008 May 13.

PMID:
18477732
6.

Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS, Gerevich J.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):756-60. Epub 2007 Jan 16.

PMID:
17289236
7.

Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009.

Xiang YT, Buchanan RW, Ungvari GS, Chiu HF, Lai KY, Li YH, Si TM, Wang CY, Lee EH, He YL, Yang SY, Chong MY, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Tan CH, Shinfuku N.

PLoS One. 2013 Jun 10;8(6):e66154. doi: 10.1371/journal.pone.0066154. Print 2013.

8.

Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).

Li Q, Xiang YT, Su YA, Shu L, Yu X, Correll CU, Ungvari GS, Chiu HF, Ma C, Wang GH, Bai PS, Li T, Sun LZ, Shi JG, Chen XS, Mei QY, Li KQ, Si TM, Kane JM.

Schizophr Res. 2015 Oct;168(1-2):523-9. doi: 10.1016/j.schres.2015.07.048. Epub 2015 Aug 12.

PMID:
26277534
9.

Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Pharmacopsychiatry. 2007 Nov;40(6):269-74.

PMID:
18030651
10.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
11.

Prescribing for inpatients with schizophrenia: an international multi-center comparative study.

Bitter I, Chou JC, Ungvari GS, Tang WK, Xiang Z, Iwanami A, Gaszner P.

Pharmacopsychiatry. 2003 Jul;36(4):143-9.

PMID:
12905100
12.

Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in China.

Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS.

Int J Clin Pharmacol Ther. 2008 May;46(5):245-51.

PMID:
18538110
13.

Clozapine prescription and quality of life in Chinese patients with schizophrenia treated in primary care.

Hou CL, Cai MY, Ma XR, Zang Y, Jia FJ, Lin YQ, Chiu HF, Ungvari GS, Ng CH, Zhong BL, Cao XL, Li Y, Shinfuku N, Xiang YT.

Pharmacopsychiatry. 2015 Sep;48(6):200-4. doi: 10.1055/s-0035-1555939. Epub 2015 Aug 5.

PMID:
26244858
14.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
15.

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

Chong MY, Tan CH, Fujii S, Yang SY, Ungvari GS, Si T, Chung EK, Sim K, Tsang HY, Shinfuku N.

Psychiatry Clin Neurosci. 2004 Feb;58(1):61-7.

PMID:
14678459
16.

Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.

Taylor DM, Young C, Paton C.

J Clin Psychiatry. 2003 Jan;64(1):30-4.

PMID:
12590620
17.

[Ten years of clinical experience with clozapine about 170 patients].

Levoyer D, Martinet JP, Badiche A, Millet B.

Encephale. 2004 May-Jun;30(3):285-95. French.

PMID:
15235527
18.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
19.

Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.

Weinbrenner S, Assion HJ, Stargardt T, Busse R, Juckel G, Gericke CA.

Pharmacopsychiatry. 2009 Mar;42(2):66-71. doi: 10.1055/s-0028-1103293. Epub 2009 Mar 23.

PMID:
19308881
20.

Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.

Xiang YT, Weng YZ, Leung CM, Tang WK, Sandor UG.

Hum Psychopharmacol. 2007 Apr;22(3):173-80. Erratum in: Hum Psychopharmacol. 2007 Jun;22(4):255. Ungvari, Gabor Sandor [corrected to Sandor, Ungvari Gabor].

PMID:
17397098
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk